245 related articles for article (PubMed ID: 26348210)
1. Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA Nephropathy.
Kim YG; Alvarez M; Suzuki H; Hirose S; Izui S; Tomino Y; Huard B; Suzuki Y
PLoS One; 2015; 10(9):e0137044. PubMed ID: 26348210
[TBL] [Abstract][Full Text] [Related]
2. A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy.
Myette JR; Kano T; Suzuki H; Sloan SE; Szretter KJ; Ramakrishnan B; Adari H; Deotale KD; Engler F; Shriver Z; Wollacott AM; Suzuki Y; Pereira BJG
Kidney Int; 2019 Jul; 96(1):104-116. PubMed ID: 31027890
[TBL] [Abstract][Full Text] [Related]
3. Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA Nephropathy.
Takahata A; Arai S; Hiramoto E; Kitada K; Kato R; Makita Y; Suzuki H; Nakata J; Araki K; Miyazaki T; Suzuki Y
J Am Soc Nephrol; 2020 Sep; 31(9):2013-2024. PubMed ID: 32611589
[TBL] [Abstract][Full Text] [Related]
4. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.
Hashimoto A; Suzuki Y; Suzuki H; Ohsawa I; Brown R; Hall S; Tanaka Y; Novak J; Ohi H; Tomino Y
Am J Pathol; 2012 Oct; 181(4):1338-47. PubMed ID: 22871574
[TBL] [Abstract][Full Text] [Related]
5. A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.
Takahara M; Nagato T; Nozaki Y; Kumai T; Katada A; Hayashi T; Harabuchi Y
Cell Immunol; 2019 Jul; 341():103925. PubMed ID: 31088610
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy.
Zuo N; Suzuki Y; Sugaya T; Osaki K; Kanaguchi Y; Wang L; Tomino Y
Nephrol Dial Transplant; 2011 Jul; 26(7):2127-37. PubMed ID: 21109611
[TBL] [Abstract][Full Text] [Related]
7. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.
Makita Y; Suzuki H; Kano T; Takahata A; Julian BA; Novak J; Suzuki Y
Kidney Int; 2020 Feb; 97(2):340-349. PubMed ID: 31748116
[TBL] [Abstract][Full Text] [Related]
8. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 12 induces crescentic glomerular lesions in a high IgA strain of ddY mice, independently of changes in IgA deposition.
Nogaki F; Muso E; Kobayashi I; Kusano H; Shirakawa K; Kamata T; Oyama A; Ono T; Miyawaki S; Yoshida H; Sasayama S
Nephrol Dial Transplant; 2000 Aug; 15(8):1146-54. PubMed ID: 10910437
[TBL] [Abstract][Full Text] [Related]
10. Enhanced production of glomerular extracellular matrix in a new mouse strain of high serum IgA ddY mice.
Muso E; Yoshida H; Takeuchi E; Yashiro M; Matsushima H; Oyama A; Suyama K; Kawamura T; Kamata T; Miyawaki S; Izui S; Sasayama S
Kidney Int; 1996 Dec; 50(6):1946-57. PubMed ID: 8943478
[TBL] [Abstract][Full Text] [Related]
11. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
Roos A; Rastaldi MP; Calvaresi N; Oortwijn BD; Schlagwein N; van Gijlswijk-Janssen DJ; Stahl GL; Matsushita M; Fujita T; van Kooten C; Daha MR
J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
[TBL] [Abstract][Full Text] [Related]
12. Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy.
Kajiyama T; Suzuki Y; Kihara M; Suzuki H; Horikoshi S; Tomino Y
Clin Dev Immunol; 2011; 2011():819646. PubMed ID: 21765852
[TBL] [Abstract][Full Text] [Related]
13. Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes.
Kuboi Y; Nishimura M; Ikeda W; Nakatani T; Seki Y; Yamaura Y; Ogawa K; Hamaguchi A; Muramoto K; Mizuno K; Ogasawara H; Yamauchi T; Yasuda N; Onodera H; Imai T
Int Immunol; 2019 Apr; 31(5):287-302. PubMed ID: 30668715
[TBL] [Abstract][Full Text] [Related]
14. Schisandrin B Improves the Renal Function of IgA Nephropathy Rats Through Inhibition of the NF-κB Signalling Pathway.
Qin JH; Lin JR; Ding WF; Wu WH
Inflammation; 2019 Jun; 42(3):884-894. PubMed ID: 30519926
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptor antagonist modulates the progression of a spontaneously occurring IgA nephropathy in mice.
Chen A; Sheu LF; Chou WY; Tsai SC; Chang DM; Liang SC; Lin FG; Lee WH
Am J Kidney Dis; 1997 Nov; 30(5):693-702. PubMed ID: 9370186
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-1 levels are increased in patients with IgA nephropathy.
Tokunaga K; Uto H; Takami Y; Mera K; Nishida C; Yoshimine Y; Fukumoto M; Oku M; Sogabe A; Nosaki T; Moriuchi A; Oketani M; Ido A; Tsubouchi H
Biochem Biophys Res Commun; 2010 Aug; 399(2):144-9. PubMed ID: 20637724
[TBL] [Abstract][Full Text] [Related]
17. Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy.
Zhai YL; Zhu L; Shi SF; Liu LJ; Lv JC; Zhang H
Medicine (Baltimore); 2016 Mar; 95(11):e3099. PubMed ID: 26986150
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
Sugiyama M; Wada Y; Kanazawa N; Tachibana S; Suzuki T; Matsumoto K; Iyoda M; Honda H; Shibata T
PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
[TBL] [Abstract][Full Text] [Related]
19. Increased Tim-3
Hou J; Zhang L; Wu H; Gao P; Xu Z
Int Immunopharmacol; 2021 Aug; 97():107666. PubMed ID: 34058623
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice.
Rops ALWMM; Jansen E; van der Schaaf A; Pieterse E; Rother N; Hofstra J; Dijkman HBPM; van de Logt AE; Wetzels J; van der Vlag J; van Spriel AB
Kidney Int; 2018 Jun; 93(6):1356-1366. PubMed ID: 29551516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
